ResearcherChina Medical UniversityActive in the last 2 years

Yanjie Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3101-0952; OpenAlex author ID A5100601301. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDAC. Co-author DOI 10.1016/j.isci.2026.115316 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fu-Ying Zhao · 1 shared paper, 2026 · strength 0.33
- Paper Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDAC. DOI 10.1016/j.isci.2026.115316 ↗
Huaqin Wang · 1 shared paper, 2026 · strength 0.33
- Paper Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDAC. DOI 10.1016/j.isci.2026.115316 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.